Table 2.
Study population 6 and 12 months after surgery
| Total | SG | RYGB | p-value | ||
|---|---|---|---|---|---|
| BMI (kg/m2) | 6 months | 39.7 (0.56) | 41.1 (0.95) | 38.5 (0.62) | 0.446 |
| 12 months | 35.7 (0.55) | 37.7 (0.95) | 34.2 (0.6) | 0.132 | |
| %EBMIL | 6 months | 49 (1.3) | 46 (2) | 51 (1.6) | 0.147 |
| 12 months | 62 (1.6) | 57 (2.4) | 66 (2.1) | 0.013* | |
| LiMAx (μg/kg/h) | 6 months | 322.6 (12.1) | 324.8 (19.4) | 320.6 (14.9) | 0.862 |
| 12 months | 359.6 (12.6) | 367.0 (15.7) | 348.6 (21) | 0.485 | |
| Abnormal liver function test results (LiMAx < 315 μg/kg/h) | 6 months | 43 (47.3%) | 21 (47.7%) | 22 (46.8) | 0.930 |
| 12 months | 48 (64%) | 31 (68.9%) | 17 (56.7%) | 0.280 | |
| APRI | 6 months | 0.0831 (0.002) | 0.0838 (0.004) | 0.0824 (0.003) | 0.143 |
| 12 months | 0.0837 (0.003) | 0.0774 (0.004) | 0.0892 (0.004) | 0.103 | |
| T2DM | 6 months | 17 (12%) | 9 (13%) | 8 (11%) | 0.704 |
| 12 months | 16 (11%) | 8 (11%) | 8 (11%) | 0.884 |